Publications

Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial

AuthID
P-00F-XQR

Author(s)

Dodel, R

Rominger, A

Bartenstein, P

Barkhof, F

Blennow, K

Forster, S

Winter, Y

Bach, JP

Popp, J

Alferink, J

Wiltfang, J

[+3]·

Jacoby, M

Richter, R

Stevens, J

Melamed, I

Goldstein, J

Haag, S

Wietek, S

Farlow, M

Jessen, F

View all authors

Document Type

Article

Year published

2013

Published

in The Lancet Neurology, ISSN: 1474-4422

Volume: 12, Issue: 3, Pages: 233-243

Indexing

Scopus^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/s1474-4422(13)70014-0

Pubmed: 23375965

Scopus: 2-s2.0-84876307732

Source Identifiers

ISSN: 1474-4422

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Name	Name Order	Name	Name Order	Name
1	Dodel, R;	2	Rominger, A;	3	Bartenstein, P;
4	Barkhof, F;	5	Blennow, K;	6	Forster, S;
7	Winter, Y;	8	Bach, JP;	9	Popp, J;
10	Alferink, J;	11	Wiltfang, J;	12	Buerger, K;
13	Otto, M;	14	Antuono, P;	15	Jacoby, M;
16	Richter, R;	17	Stevens, J;	18	Melamed, I;
19	Goldstein, J;	20	Haag, S;	21	Wietek, S;
22	Farlow, M;	23	Jessen, F;

Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial

Useful Links

Get Help

Federated Authentication (Click on the image)

Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial

Useful Links

Get Help